News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Revolo Biotherapeutics Unveils New Phase 2a Trial Findings of '1104 in Adults With Active Eosinophilic Esophagitis
Wednesday, July 19, 2023Revolo Biotherapeutics has unveiled additional data from its Phase a clinical trial investigating the effectiveness safety and tolerability of their immuneresetting drug in adults with active eosinophilic esophagitis EoE a chronic allergic inflammat...
Grifols Successfully Concludes Phase 3 Enrollment for Long-term Albutein® Therapy in Patients With Decompensated Cirrhosis
Wednesday, July 19, 2023Grifols a renowned producer of plasmaderived medications has successfully concluded the enrollment phase for PRECIOSA NCT a phase clinical trial
LIXTE Biotechnology and the Netherlands Cancer Institute Unveil Novel Mechanism for LB-100, Enhancing Immunotherapy and Chemotherapy Effectiveness in Preclinical Results
Tuesday, July 18, 2023LIXTE Biotechnology Holdings Inc LIXTE or the Company has made a significant breakthrough in cancer research through a fruitful collaboration with the Netherlands Cancer Institute
Clearside Biomedical Commences Enrolling Numerous Participants in ODYSSEY Phase 2b Clinical Trial Assessing CLS-AX (Axitinib Injectable Suspension) for Wet AMD
Tuesday, July 18, 2023Clearside Biomedical Inc Nasdaq CLSD is a biopharmaceutical company focused on revolutionizing the delivery of therapies for eye conditions by utilizing the suprachoroidal space SCS
Adcentrx Therapeutics Receives FDA Clearance for Investigational New Drug Application of ADRX-0706, an Innovative ADC Targeting Nectin-4 to Treat Advanced Solid Tumors
Tuesday, July 18, 2023Adcentrx Therapeutics is a pioneering biotechnology company dedicated to revolutionizing AntibodyDrug Conjugate ADC therapies for cancer and other lifethreatening diseases Recently the US Food and Drug Administration FDA granted clearance to Adcentrx...
Compass Pathways Releases Promising Findings From Phase 2 Clinical Trial of COMP360 Psilocybin With Antidepressants in Neuropsychopharmacology, a Nature Journal
Monday, July 17, 2023COMPASS Pathways plc Nasdaq CMPS has made an announcement regarding the publication of favorable data from an openlabel phase clinical trial in the esteemed journal Neuropsychopharmacology
Camurus Announces Phase 3 Trial Findings Supporting the Long-term Safety and Efficacy of Octreotide Sc Depot (CAM2029) in Acromegaly Patients
Monday, July 17, 2023Camurus a company listed on NASDAQ STO under the ticker symbol CAMX has recently shared interim topline data from a clinical trial called ACROINNOVA
Eucorvac-19 COVID-19 Vaccine by POP Biotechnologies and Eubiologics Achieves Target in Phase 3 Trial
Saturday, July 15, 2023Buffalobased biopharmaceutical startup POP Biotechnologies POP BIO has recently announced the interim results of a Phase clinical trial for EuCorVac a COVID vaccine candidate developed in partnership with South Korean company EuBiologics KOSDAQ
Positive Phase III Results Revealed for Roche's OCREVUS (Ocrelizumab): Twice-yearly, 10-minute Subcutaneous Injections in Multiple Sclerosis Patients
Friday, July 14, 2023Roche a pharmaceutical company has announced positive results from a recent clinical trial known as OCARINA II The trial investigated the use of OCREVUS ocrelizumab as a subcutaneous injection for the treatment of multiple sclerosis MS
Grifols Successfully Enrolls Participants in Phase 3 Study Evaluating Two Dose Regimens of Prolastin®-c for Emphysema Caused by Alpha-1-antitrypsin Deficiency
Friday, July 14, 2023Grifols a major producer of plasmaderived medications has announced that it has successfully enrolled patients in its phase clinical trial called SPARTA Study of ProlAstinc Randomized Therapy with Alpha augmentation NCT
